Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://covid19.nih.gov/

Results: 63 (Showing 1 to 5)
PLCO EEMS Round 32 open for preliminary applications from Feb 24 to Aug 17, 2021
Posted by CDAS Administrator on Feb. 24, 2021, 7:06 a.m. in PLCO

Preliminary applications will only be accepted from February 24 to August 17, 2021. If you plan to submit an EEMS application this cycle, an approved preliminary application is required. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application.

The full application deadline is October 1, 2021. The full applications will undergo panel review and final outcome notifications will be sent in early December 2021.

Information is available regarding the PLCO trial and PLCO biospecimens.

Please visit the EEMS Application for Biospecimens page to preview instructions about the process, review the EEMS Policies and Procedures, and begin an EEMS Preliminary Application for Biospecimens.

If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

IDATA Biospecimen Round 7 open for preliminary applications from Feb 19 to Aug 6, 2021
Posted by CDAS Administrator on Feb. 19, 2021, 5:23 a.m. in IDATA

Preliminary applications will only be accepted from February 19 to August 6, 2021. If you plan to submit an IDATA Biospecimen application this cycle, an approved preliminary application is required. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application.

The full application deadline is September 14, 2021. The full applications will undergo panel review and final outcome notifications will be sent by mid-November 2021.

Information is available regarding the IDATA study and IDATA biospecimens.

Please visit the IDATA Application for Biospecimens page to preview instructions about the process, review the IDATA Biospecimen Policies and Procedures, and begin an IDATA Preliminary Application for Biospecimens.

If you have any questions, please contact CDAS staff at cdas-idatabio@imsweb.com

The Lung Screening Study data is now available.
Posted by CDAS Administrator on Nov. 20, 2020, 4:20 p.m.

You can read more about this data and make requests at https://cdas.cancer.gov/lss/ .

Requests for Specimen Verification will only be accepted from November 15, 2020 to January 13, 2021. If you plan to submit a grant application this cycle, an approved Request for Specimen Verification is required. Once your Request for Specimen Verification has been approved, you will receive a confirmation letter to accompany your grant application.

The grant application deadline is February 11, 2021.

Information is available regarding the PLCO trial and PLCO biospecimens

Please visit the PAR Request Form for Specimen Verification page to preview instructions about the process, review the Policies and Procedures, and begin a Request for Specimen Verification.

If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

New PLCO EEMS lab results files available
Posted by CDAS Administrator on Nov. 4, 2020, 4:52 p.m. in PLCO

Data for published PLCO EEMS studies are being published on CDAS on a weekly basis as they are released. New results search functionality has been implemented to easily search the available analytes. https://cdas.cancer.gov/learn/plco/lab-results/browse/

Please note, for each of these studies markers were measured independently using various platforms as referenced in their corresponding publications. The publications can be found by clicking on the study ID for each project. Please use caution when pooling data across different case-control studies.